NemaLife is at Expo West! Schedule a meeting with our representatives!

We launched new services to accelerate and derisk your product development. Choose your specialty below.

The costs and timeframe of new product development can be prohibitive especially when the development cycle involves multiple iterations of a formulation and other variables.

At NemaLife, we specialize in helping organizations to increase the speed of data acquisition while lowering the associated costs of new product testing. We achieve this through our industry-leading microfluidic technology, which is the product of our team’s deep engineering and life science expertise.

We designed our platform to provide our clients with high-quality scientific data to back up their product claims. Our data is free from mammalian testing, which is associated with negative consumer opinions. We believe our platform offers clients a future-proof testing environment that takes into account the regulatory landscape in the US and Europe.



Dr. Tom LaRocca

Assistant Professor

Health and Exercise Science

Center for Healthy Aging


“I expect this new system to become a gold standard for pharmacological testing of longevity compounds in C. elegans. It allows to test for effects on longevity without the need of FuDR and enables repeated and controlled dosing of compounds which is difficult or impossible with other systems”

Michael Petrascheck Ph.D.


“NemaLife provides a route to rapid and inexpensive dose-response assessment of pharmacological interventions, reduces manual labor associated with classical approaches to survival assays, and enables health evaluation over lifetime - increasing our throughput”

Monica Driscoll Ph.D.


"We were interested in NemaLife chips because they appear to allow individuals in liquid phase to exhibit behaviors similar to what they'd show on agar plates. It was very easy to order chips from Nemalife, and we've learned a lot working with these devices." 

Nicholas Stroustrup Ph.D.

Our Academic Partners